Highlights from the 2024 CHDI HD Therapeutics Conference

Published: May 21, 2024

Highlights from the 2024 CHDI HD Therapeutics Conference || Palm Springs 26 – 29 February 2024
Including Clinical Trial updates from PTC Therapeutics, Wave Life Sciences UniQure and Roche

  • Categories

    • Related News

    Wave Life Sciences Announces Positive Results from Phase 1B/2A SELECT-HD Trial

    June 26, 2024

    Great news on the positive results! Read all the details below. Community Letter Press Release

    Highlights from the 2024 CHDI HD Therapeutics Conference

    May 21, 2024

    Highlights from the 2024 CHDI HD Therapeutics Conference || Palm Springs 26 – 29 February 2024 Including Clinical Trial updates from PTC Therapeutics, Wave Life…

    uniQure gets the green light to resume testing HD gene therapy

    November 5, 2022

    In August 2022, uniQure announced a pause in new recruitment for their trial of AMT-130, an HD gene therapy delivered via brain surgery. The decision…

    WAVE Announcement

    October 1, 2021

    Wave Life Sciences Announces Initiation of Dosing in Phase 1b_2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease